Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New therapeutic results in osteosarcoma]

C Urban, G Rosen

    Wiener Medizinische Wochenschrift (1946)
    |July 31, 1982
    PubMed
    Summary

    Neoadjuvant chemotherapy before surgery improves outcomes for osteosarcoma patients. This approach allows for tailored treatment strategies, leading to a 93% disease-free survival rate in a recent study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel case of combination antibiotic therapy for treatment of a complicated polymicrobial urinary tract infection with one organism harboring a metallo-β-lactamase (MBL) in a pregnant patient.

    IDCases·2024
    Same author

    <i>Edwardsiella tarda</i>, a rare human pathogen isolated from a perihepatic abscess: Implications of transient versus long term colonization of the gastrointestinal tract.

    IDCases·2021
    Same author

    Novel double beta-lactam therapy for <i>Granulicatella adiacens</i> infective endocarditis.

    IDCases·2021
    Same author

    Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2019
    Same author

    Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.

    Pediatric blood & cancer·2018
    Same author

    False positive serum levels of (1-3)-ß-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation.

    The Journal of infection·2017

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Medical Oncology

    Context:

    • Osteosarcoma treatment traditionally involves surgery, but delays for postoperative therapy can be detrimental.
    • Primary systemic chemotherapy followed by delayed surgery offers improved limb preservation and survival outcomes.
    • Histologic evaluation of resected tumors is crucial for assessing chemotherapy response and identifying high-risk patients.

    Purpose:

    • To evaluate the efficacy of neoadjuvant chemotherapy followed by delayed surgery in osteosarcoma patients.
    • To determine if early modification of chemotherapy based on histologic response improves outcomes.
    • To establish a model for individualized, risk-stratified treatment of osteosarcoma.

    Summary:

    • A neoadjuvant chemotherapy approach for osteosarcoma, with surgery performed only if limb preservation is feasible, yielded superior results compared to primary surgery.
    • Histologic assessment post-chemotherapy identified non-responders, allowing for timely alternative treatment strategies.
    • This individualized treatment model resulted in a 93% disease-free survival rate at a median of 20 months.

    Impact:

    • The study demonstrates the benefit of neoadjuvant chemotherapy in osteosarcoma, achieving high disease-free survival rates.
    • This approach allows for personalized treatment adjustments based on individual tumor response.
    • The success of this neoadjuvant model suggests its potential applicability to other highly malignant tumors.

    Related Experiment Videos